SCHEMBL29630910

SCHEMBL29630910

CS(=O)(=O)OC(COCc1ccccc1)CN(Cc1ccccc1)S(C)(=O)=O

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PER2 O15055 2/20 0.44
CRY1 Q16526 2/20 0.44
CRY2 Q49AN0 2/20 0.44
SMN1; SMN2 Q16637 3/20 0.43
ALDH1A1 P00352 3/20 0.43
POLB P06746 1/20 0.43
CA2 P00918 2/20 0.40
APLNR P35414 1/20 0.39
MEN1 O00255 1/20 0.39
MAPT P10636 1/20 0.39
KMT2A Q03164 1/20 0.39
RORC P51449 3/20 0.39
LMNA P02545 1/20 0.39
GAA P10253 2/20 0.38
TSHR P16473 1/20 0.37
NR1I2 O75469 1/20 0.37
RORA P35398 1/20 0.37
NR1H2 P55055 1/20 0.37
NR1H3 Q13133 1/20 0.37
RORB Q92753 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18186635 0.84 TSHR (0.47) SMN1; SMN2CA2KMT2ATSHRCA1
SCHEMBL11033646 0.82 TSHR (0.41) SMN1; SMN2CA2MEN1MAPTKMT2A
SCHEMBL25486668 0.80 TSHR (0.42) SMN1; SMN2CA2KMT2ATSHRCA1
SCHEMBL25389273 0.80 CRY1 (0.46) PER2CRY1CRY2SMN1; SMN2ALDH1A1
SCHEMBL16757114 0.76 TDP1 (0.39) CA2MEN1MAPTKMT2ATSHR
SCHEMBL10689073 0.75 TSHR (0.47) SMN1; SMN2CA2KMT2ATSHRCA1
SCHEMBL6654165 0.75 TSHR (0.47) SMN1; SMN2CA2KMT2ATSHRCA1
SCHEMBL16756891 0.75 CA1 (0.40) CA2KMT2ATSHRCA1CA4
SCHEMBL17796108 0.74 TSHR (0.45) SMN1; SMN2CA2KMT2ATSHRCA1
SCHEMBL17796120 0.74 TSHR (0.45) SMN1; SMN2CA2KMT2ATSHRCA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4251623-A1 ARYLOXAZOLO SPIRAL RING DERIVATIVES FOR THE TREATMENT AND PROPHYLAXIS OF HEPATITIS B VIRUS INFECTION F. Hoffmann-La Roche AG (CH) 2023-10-04 EP disclosed
CN-116457352-A Aryloxazolo spiro derivatives for the treatment and prophylaxis of hepatitis b virus infection 豪夫迈·罗氏有限公司 2023-07-18 CN disclosed
WO-2022112140-A1 ARYLOXAZOLO SPIRAL RING DERIVATIVES FOR THE TREATMENT AND PROPHYLAXIS OF HEPATITIS B VIRUS INFECTION F. HOFFMANN-LA ROCHE AG (CH) 2022-06-02 WO disclosed